life science portfolio support for investors

 

ad-hoc management
  • alignment of relevant internal & external stakeholders, strategic leadership, resource allocation for optimal return-on-investment
  • day-to-day (project)management

operation due diligence / M&A guidance

  • identification and assessment of value determinants & overall valuation, scenario planning, sensitivity analysis, realistic potential
  • preclinical, manufacturing & regulatory evaluation: mode-of-action, proof-of-concept, product characterisation and production validation
  • clinical program assessment: efficacy, relevance of clinical data, expert endorsement, ability to address market access requirements
  • competitive environment and benchmarking versus marketed and emerging¬†products/technologies, market potential estimation